Silent myocardial ischemia adversely affects prognosis in patients with coronary artery disease, suggesting a need for detection and treatment.
Answers are grounded in this paper and cite their sources.
Silent ischemia supports inclusion in CAD risk stratification; leaves open whether detection or treatment improves outcomes.
Silent myocardial ischemia is increasingly recognized as a common phenomenon in a variety of people with coronary artery disease. The natural history is poorly understood, but available data suggest that silent ischemia adversely affects prognosis in all groups studied. Based on this information, we believe that efforts should be directed at detecting and aggressively treating silent ischemic episodes.
No takes yet. Share an insight, caveat, or question.
Hill et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: